Cargando…
Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues
Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244545/ https://www.ncbi.nlm.nih.gov/pubmed/30167993 http://dx.doi.org/10.1007/s11307-018-1267-y |
_version_ | 1783372076137054208 |
---|---|
author | Porta Siegel, Tiffany Hamm, Gregory Bunch, Josephine Cappell, Jo Fletcher, John S. Schwamborn, Kristina |
author_facet | Porta Siegel, Tiffany Hamm, Gregory Bunch, Josephine Cappell, Jo Fletcher, John S. Schwamborn, Kristina |
author_sort | Porta Siegel, Tiffany |
collection | PubMed |
description | Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, i.e., increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and ex vivo molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes. |
format | Online Article Text |
id | pubmed-6244545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-62445452018-12-04 Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues Porta Siegel, Tiffany Hamm, Gregory Bunch, Josephine Cappell, Jo Fletcher, John S. Schwamborn, Kristina Mol Imaging Biol Review Article Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, i.e., increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and ex vivo molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes. Springer International Publishing 2018-08-30 2018 /pmc/articles/PMC6244545/ /pubmed/30167993 http://dx.doi.org/10.1007/s11307-018-1267-y Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Porta Siegel, Tiffany Hamm, Gregory Bunch, Josephine Cappell, Jo Fletcher, John S. Schwamborn, Kristina Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues |
title | Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues |
title_full | Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues |
title_fullStr | Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues |
title_full_unstemmed | Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues |
title_short | Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues |
title_sort | mass spectrometry imaging and integration with other imaging modalities for greater molecular understanding of biological tissues |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244545/ https://www.ncbi.nlm.nih.gov/pubmed/30167993 http://dx.doi.org/10.1007/s11307-018-1267-y |
work_keys_str_mv | AT portasiegeltiffany massspectrometryimagingandintegrationwithotherimagingmodalitiesforgreatermolecularunderstandingofbiologicaltissues AT hammgregory massspectrometryimagingandintegrationwithotherimagingmodalitiesforgreatermolecularunderstandingofbiologicaltissues AT bunchjosephine massspectrometryimagingandintegrationwithotherimagingmodalitiesforgreatermolecularunderstandingofbiologicaltissues AT cappelljo massspectrometryimagingandintegrationwithotherimagingmodalitiesforgreatermolecularunderstandingofbiologicaltissues AT fletcherjohns massspectrometryimagingandintegrationwithotherimagingmodalitiesforgreatermolecularunderstandingofbiologicaltissues AT schwambornkristina massspectrometryimagingandintegrationwithotherimagingmodalitiesforgreatermolecularunderstandingofbiologicaltissues |